News | Magnetic Resonance Imaging (MRI) | November 24, 2015

Researchers used 3-D MRI to study the carotid arteries in diabetic patients for evidence of intraplaque hemorrhage (IPH), an indicator of advanced atherosclerotic disease

IPH, intraplaque hemorrhage, diabetic patients, stroke risk, 3-D MRI

Image A shows the 3-D MRI intraplaque hemorrhage (IPH) sequence as acquired in the coronal plane. The red dotted line indicates the level at which the reformatted axial plane, B, was obtained. C shows the section of the right carotid artery with a region of high signal consistent with IPH. Contours are drawn for the outer wall (green) and lumen (red) with the area of IPH in this segment shaded blue in D.


November 24, 2015 — People with diabetes may be harboring advanced vascular disease that could increase their risk of stroke, according to new research being presented next week at the annual meeting of the Radiological Society of North America (RSNA). The findings suggest that arterial imaging with 3-D magnetic resonance imaging (MRI) could be useful in helping to determine stroke risk among diabetics.

The carotid arteries are vessels on each side of the neck that supply oxygenated blood to the head. Narrowing of the carotid arteries is associated with risk of stroke, but less is known about stroke risk in people with little or no narrowing of these arteries.

For the new study, researchers used 3-D MRI to study the carotid arteries for evidence of intraplaque hemorrhage (IPH), an indicator of advanced atherosclerotic disease.

"A recent analysis of multiple studies has shown that people with carotid artery narrowing and IPH have a five- to six-times higher risk of stroke in the near future compared to people without," said study author Tishan Maraj, M.B.B.S., imaging analyst at Sunnybrook Research Institute and M.Sc. candidate at the University of Toronto in Toronto, Canada.

Maraj and colleagues focused their study on people with diabetes, a group already facing a significantly increased risk of strokes with worse outcomes than the non-diabetic population. They used 3-D MRI to investigate the prevalence of carotid IPH in 159 asymptomatic type 2 diabetic patients, average age 63, recruited from a dietary trial between 2010 and 2013.

Of the 159 patients imaged, 37, or 23.3 percent, had IPH in at least one carotid artery. Five of the 37 patients had IPH in both carotid arteries. IPH was found in the absence of carotid artery stenosis, or narrowing, and was associated with an increased carotid artery wall volume as measured by 3-D MRI.

"It was surprising that so many diabetic patients had this feature," Maraj said. "We already knew that people with diabetes face three to five times the risk of stroke, so perhaps IPH is an early indicator of stroke risk that should be followed up."

While 2-D MRI has been used for more than a decade to identify and characterize carotid artery plaques, the 3-D method brings an extra level of imaging power, Maraj noted.

"The advantage of 3-D MRI is you can image the entire carotid artery and pinpoint the area of interest over a shorter period of time compared with multiple 2-D sequences," he said.

Maraj emphasized that the study did not look at outcomes for the patients and did not draw any conclusions on whether people with IPH will develop carotid artery blockages more quickly than those with no IPH present. However, it is already known that blood is a destabilizing factor of plaque that promotes rupture, setting off a chain of events that can lead to a stroke.

Although there is no treatment for IPH at this time, Maraj said identification of it may help with risk stratification and could even have applications in the non-diabetic population.

"Even though you can't treat IPH, you can monitor patients a lot more closely," he said.

Co-authors on the study are Alan R. Moody, M.D., FRCP, FRCR; Navneet Singh, M.D.; Tina Binesh Marvasti, M.Sc.; Mariam Afshin, Ph.D., M. Eng.; Pascal N. Tyrrell, Ph.D.; and David Jenkins, M.D., Ph.D., D.Sc.

For more information: www.radiologyinfo.org


Related Content

News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Breast Imaging

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that ...

Time May 16, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Computed Tomography (CT)

Feb. 25, 2025 —Stratasys Ltd. and Siemens Healthineers recently presented the results of a joint research effort that ...

Time March 04, 2025
arrow
News | Artificial Intelligence

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 ...

Time February 04, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Artificial Intelligence

Dec. 12, 2024 — At RSNA 2024, Careverse officially made its debut, exhibiting in the AI Showcase area, sharing its ...

Time December 18, 2024
arrow
News | Artificial Intelligence

Dec. 17, 2024 — Radin Health, a provider of advanced radiology AI-Powered solutions, highlighted its All-in-One ...

Time December 18, 2024
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
Subscribe Now